RxDoctor Payments Data

Winnie Stuempfle

Pediatric Hematology-Oncology · Glendale, AZNPI 1407448046

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.7% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 35.6% of the total.

$3,402in general payments, 2019–2025

Across 74 payments — averaging $45.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$1K
  • Incyte Corporation$495
  • Bayer$203
  • United Therapeutics Corporation$163
  • USWM, LLC$158
  • AstraZeneca$131
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,15493%
  • Education$2487%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,402 in reported general payments places this provider in the 70th percentile of 42 pediatric hematology-oncology providers in Arizona.

See all pediatric hematology-oncology providers in Arizona

Other pediatric hematology-oncology in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →